Please use this identifier to cite or link to this item:
|Title:||Evidence behind the WHO guidelines: what is the most appropriate anti-fungal treatment for acute cryptococcal meningitis in children with HIV?|
|Publisher:||Oxford University Press|
|Place of publication:||Oxford|
|Publication Title:||Journal of Tropical Pediatrics|
|Abstract:||The World Health Organization has produced guidelines for the management of common illnesses in hospitals with limited resources. This series reviews the scientific evidence behind WHO’s recommendations. The WHO guidelines and more reviews are available at: http://www.ichrc.org. The WHO Pocketbook of Hospital Care for Children  recommends treating children with cryptococcal meningitis with intravenous amphotericin B (0.5–1.5 mg kg−1 day−1) for 14 days followed by oral fluconazole (3–6 mg kg−1 day−1) for 8 weeks. Following the management of an acute episode, current recommendations advise ongoing prophylaxis with fluconazole. This review addresses the question: what is the most appropriate anti-fungal treatment for acute cryptococcal meningitis in children with HIV?|
|Internal ID Number:||00153|
|Appears in Collections:||Research Output|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.